Livmarli (maralixibat) — United Healthcare
Alagille syndrome (ALGS)
Initial criteria
- Diagnosis of Alagille syndrome (ALGS)
- Patient is experiencing pruritus associated with ALGS
Reauthorization criteria
- Documentation of positive clinical response to Livmarli therapy
Approval duration
12 months